Investigation on status of dyslipidemia in Chinese females aged 35 years or above.
10.3760/cma.j.cn112148-20211201-01035
- Author:
Ming Yan MA
1
;
Xue Lian CHEN
1
;
Zuo CHEN
2
;
Xin WANG
2
;
Lin Feng ZHANG
2
;
Su Ning LI
2
;
Cong Yi ZHENG
2
;
Yu Ting KANG
2
;
Hao Qi ZHOU
2
;
Lu CHEN
2
;
Xue CAO
2
;
Ji Hong HU
1
;
Zeng Wu WANG
2
Author Information
1. School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.
2. Department of Community Prevention and Treatment, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 102308, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Cardiovascular Diseases;
China/epidemiology*;
Cross-Sectional Studies;
Dyslipidemias/epidemiology*;
Female;
Humans;
Middle Aged;
Obesity/epidemiology*;
Prevalence;
Retrospective Studies;
Risk Factors
- From:
Chinese Journal of Cardiology
2022;50(5):486-493
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the prevalence, awareness, treatment and control status of dyslipidemia among females aged ≥35 years old across China. Methods: Participants were selected by stratified multistage random sampling method in the "Twelfth Five-Year Plan" National Science and Technology Support Project "Survey on the Prevalence of Important Cardiovascular Diseases and Key Technology Research in China" project. This study is a retrospective, cross-sectional study. A total of 17 418 females aged 35 years and over were included in the current study. The basic information such as age, medical history and menopause was collected by questionnaire. The blood lipid parameters were derived from clinical laboratory examinations. The prevalence of dyslipidemia and the rate of awareness, treatment, and control of dyslipidemia were analyzed in females aged 35 years and over. Results: The age of participants was (56.2±13.0) years old, and the prevalence of dyslipidemia was 33.1% (5 765/17 418). The prevalence rates of high total cholesterol, hypertriglyceridemia, low HDL-C and high LDL-C were 9.7% (1 695/17 418), 11.1% (1 925/17 418), 10.9% (1 889/17 418) and 7.3% (1 262/17 418), respectively. The prevalence of dyslipidemia increased with age and the prevalence of dyslipidemia in women who were not married, Han, menarche age>16 years, obesity, central obesity, alcohol consumption, diabetes, hypertension and family history of cardiovascular disease were higher than those without such characteristics (P<0.05). There were 10 432 (59.9%) menopausal females in this cohort and prevalence of dyslipidemia of these participants was 38.8% (4 048/10 432), which was higher than that of non-postmenopausal females (24.6%, 1 717/6 986) (P<0.05). The awareness rates, treatment rates and control rates of dyslipidemia were 33.9% (1 953/5 765), 15.1% (870/5 765) and 2.5% (143/5 765) respectively among females aged 35 years and over in China. Conclusion: The prevalence of dyslipidemia in Chinese females aged 35 years and over is high, and its awareness, treatment, and control rates need to be optimized.
